Eli Lilly, Novo Nordisk get growth stock status on weight-loss drug boost
(Repeats Feb 16 story with no changes to text) By Medha Singh and Manas Mishra (Reuters) – U.S.-based Eli Lilly…
(Repeats Feb 16 story with no changes to text) By Medha Singh and Manas Mishra (Reuters) – U.S.-based Eli Lilly…
BEIJING/SHANGHAI (Reuters) -China’s securities watchdog said it held a series of seminars on Sunday and Monday with market participants who…
By Doina Chiacu WASHINGTON (Reuters) -Donald Trump, who drew criticism as U.S. president for his praise of Russian leader Vladimir…
By Sarah Young LONDON (Reuters) – Currys shares soared on Monday after Chinese online retailer JD.com joined U.S. activist investor…
By Nell Mackenzie LONDON (Reuters) -World shares struggled to climb on Monday after the chances of early interest rate cuts…
By Carolina Mandl, Amruta Khandekar and Ankika Biswas (Reuters) -U.S. stocks fell on Friday with the Nasdaq showing the largest…
By Sheila Dang and Katie Paul (Reuters) – A group of 20 tech companies announced on Friday they have agreed…
By Deborah Mary Sophia (Reuters) – Home Depot’s annual forecast will be the prime focus for investors when the U.S.…
By Lananh Nguyen (Reuters) -Goldman Sachs CEO David Solomon was awarded $31 million in compensation for 2023, up 24% from…
By Carolina Mandl, Johann M Cherian and Ankika Biswas (Reuters) -U.S. stocks closed higher on Thursday as retail sales data…